Transcept Pharma posts narrower 1st-quarter loss
Development-stage drugmaker Transcept Pharmaceuticals Inc. reported a narrower first-quarter Wednesday because of a license payment on its insomnia drug candidate Intermezzo and lower spending.
Read more on AP via Yahoo! Finance
